EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of Kuanxiong aerosol for preventing acute mountain sickness: an exploratory small-sample randomized, placebo-controlled trial

Yi-Xiu Lin, Peng-Fei Zhang, Zhe-Tao Wang, Dan Li, Jiao Luo, Shu-Ming Ji, Cheng Huang, Lei Chen

Frontiers in Physiology · 21.07.2026 · 17

DOI: 10.3389/fphys.2026.1834301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 21.07.2026. Verfasst von Yi-Xiu Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of High Altitude Medicine, Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to evaluate the potential efficacy and neurophysiological effects of Kuanxiong Aerosol (KXA) in preventing acute mountain sickness (AMS) during simulated high-altitude exposure.

Methods

In this randomized, double-blind, placebo-controlled trial, 20 healthy volunteers underwent a 6-hour hypobaric hypoxia session (simulated 4000 m) after receiving either KXA or placebo. Outcomes included the Lake Louise Score (LLS), AMS incidence, physiological parameters (SpO 2 , heart rate), cognitive performance (PMT, Symbol-Digit Modalities Test), and cerebral blood flow (CBF) measured by MRI. An exploratory post-hoc subgroup analysis was also conducted in nine participants who voluntarily received an additional KXA session in a self-controlled manner.

Results

In the main trial, KXA administration was associated with a non-significant reduction in total LLS and a decrease in AMS incidence from 50% (placebo) to 30% (KXA). No significant differences were observed in SpO 2 , cognitive tests, or global CBF. However, the KXA group showed a smaller increase and more stable heart rate profile over time. Exploratory regional CBF analyses revealed reduced perfusion in selected subregions of the limbic and control networks in the KXA group ( p < 0.05 uncorrected). In the post-hoc self-controlled subgroup (n = 9), KXA significantly reduced total LLS ( p = 0.037) and decreased AMS incidence from 44% to 0%, with trends toward improved cognitive performance.

Conclusion

KXA shows preliminary potential for alleviating AMS symptoms under simulated high-altitude conditions, possibly through cardiac and regional cerebrovascular modulation. These findings support further investigation in larger, randomized controlled trials in real-world high-altitude settings to confirm efficacy and clarify the underlying mechanisms. Chinese clinical trial registry ChiCTR2500105469.

Schlagwörter

Stichwörter der Autor:innen

Kuanxiong aerosolacute mountain sicknesshigh altitudehypobaric hypoxiaprevention

Autor:innen und Institutionen

  • Department of High Altitude Medicine, Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Rehabilitation Medicine, Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Key Laboratory of Rehabilitation Medicine in Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • West China School of Nursing, Sichuan University, Chengdu, Sichuan, China.

Zitieren

APA

Lin, Y. X., Zhang, P. F., Wang, Z. T., Li, D., Luo, J., Ji, S. M., Huang, C., & Chen, L. (2026). Effects of Kuanxiong aerosol for preventing acute mountain sickness: an exploratory small-sample randomized, placebo-controlled trial. Frontiers in Physiology, 17. https://doi.org/10.3389/fphys.2026.1834301

Vancouver

Lin YX, Zhang PF, Wang ZT, Li D, Luo J, Ji SM, et al. Effects of Kuanxiong aerosol for preventing acute mountain sickness: an exploratory small-sample randomized, placebo-controlled trial. Frontiers in Physiology. 2026;17. doi:10.3389/fphys.2026.1834301

BibTeX
@article{Lin2026,
  author = {Lin, Yi-Xiu and Zhang, Peng-Fei and Wang, Zhe-Tao and Li, Dan and Luo, Jiao and Ji, Shu-Ming and Huang, Cheng and Chen, Lei},
  title = {Effects of Kuanxiong aerosol for preventing acute mountain sickness: an exploratory small-sample randomized, placebo-controlled trial},
  journal = {Frontiers in Physiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphys.2026.1834301}
}
Kostenlos starten →